Epoch Biodesign

Epoch Biodesign
Epoch Biodesign uses enzymes to break down plastic waste into monomers for new plastic production.
About
What does Epoch Biodesign do?
Epoch Biodesign is a biotechnology company focused on developing enzymatic solutions for plastic recycling. Their technology utilizes engineered enzymes to depolymerize plastic waste into its constituent monomers, which can then be used to create virgin-quality new plastics. This approach offers a more sustainable and circular method for managing plastic waste compared to traditional recycling or disposal methods.
What is Epoch Biodesign's revenue?
StartupHub estimates Epoch Biodesign's annual revenue at $50.0M (range $33.0M to $103.8M, 43% confidence), based on comparable companies in the sector.
What is Epoch Biodesign's valuation?
StartupHub estimates Epoch Biodesign's effective valuation at $1.0B (range $723.5M to $1.3B, 41% confidence), based on comparable companies in the sector.
How much funding has Epoch Biodesign raised?
Epoch Biodesign has raised a total of $12M in funding. The most recent round on record is Funding Round.
Where is Epoch Biodesign headquartered?
Epoch Biodesign is headquartered in Cambridge, Massachusetts, United States.
When was Epoch Biodesign founded?
Epoch Biodesign was founded in 2021.
What industry does Epoch Biodesign operate in?
Epoch Biodesign operates in Biotechnology, Chemicals, Sustainability, Circular Economy, Waste Management.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.